Suppr超能文献

系统性硬化症中PROMIS-29和FACIT-呼吸困难简表的纵向评估

Longitudinal evaluation of PROMIS-29 and FACIT-dyspnea short forms in systemic sclerosis.

作者信息

Hinchcliff Monique E, Beaumont Jennifer L, Carns Mary A, Podlusky Sofia, Thavarajah Krishna, Varga John, Cella David, Chang Rowland W

机构信息

From the Department of Medicine, Division of Rheumatology, Department of Medical Social Sciences, and the Department of Preventive Medicine, Northwestern University Feinberg School of Medicine, and the Institute for Public Health and Medicine, Chicago, Illinois; Center for Lung Health, Henry Ford Hospital, Detroit, Michigan, USA.M.E. Hinchcliff, MD, MS, Assistant Professor of Medicine; M.A. Carns, MS; S. Podlusky, BA, Department of Medicine, Division of Rheumatology, Northwestern University Feinberg School of Medicine, and the Institute for Public Health and Medicine; J.L. Beaumont, MS, Statistical Analyst/Programmer, Department of Medical Social Sciences, Northwestern University Feinberg School of Medicine, and the Institute for Public Health and Medicine; K. Thavarajah, MD, MS, Clinical Assistant Professor of Medicine, Center for Lung Health, Henry Ford Hospital; J. Varga, MD, Professor of Medicine, Department of Medicine, Division of Rheumatology, Northwestern University Feinberg School of Medicine; D. Cella, PhD, Professor of Medicine, Department of Medical Social Sciences, Northwestern University Feinberg School of Medicine, and the Institute for Public Health and Medicine; R.W. Chang, MD, MPH, Professor of Medicine, Department of Medicine, Division of Rheumatology, Department of Preventive Medicine, Northwestern University Feinberg School of Medicine, and the Institute for Public Health and Medicine.

出版信息

J Rheumatol. 2015 Jan;42(1):64-72. doi: 10.3899/jrheum.140143. Epub 2014 Nov 1.

Abstract

OBJECTIVE

To assess the sensitivity of the Patient-Reported Outcomes Measurement Information System 29-item Health Profile (PROMIS-29) and the Functional Assessment of Chronic Illness Therapy-Dyspnea 10-item short form (FACIT-Dyspnea) for measuring change in health status and dyspnea in systemic sclerosis (SSc).

METHODS

One hundred patients with SSc completed the PROMIS-29, FACIT-Dyspnea, and traditional instruments [Medical Research Council Dyspnea Score, St. George's Respiratory Questionnaire (SGRQ), Health Assessment Questionnaire-Disability Index (HAQ-DI), and Medical Outcomes Study Short Form-36 (SF-36)] at baseline and 1-year visits. PROMIS-29, FACIT-Dyspnea, and traditional instrument change scores were compared across composite modified Medsger Disease Severity and modified Rodnan Skin score (mRSS) change groups.

RESULTS

Moderately high Spearman correlation coefficients were observed between FACIT-Dyspnea and SGRQ (r = 0.57), FACIT-Dyspnea functional limitations and SF-36 physical component summary (PCS; r = 0.51), PROMIS-29 physical functioning and HAQ-DI (r = 0.50), and SF-36 PCS (r = 0.52) change scores. In most validity comparisons, PROMIS-29, FACIT-Dyspnea, HAQ-DI, and SF-36 scores performed similarly. While PROMIS-29 covers more content areas than SF-36 (e.g., sleep), it may do so at the expense of responsiveness of its 4-item physical function scale as compared to the multiitem-derived SF-36 PCS. Statistically significant increases in SF-36 role physical (p = 0.01) and physical component scale (p = 0.016), but not PROMIS-29, were observed in patients with mRSS improvement.

CONCLUSION

PROMIS-29 and FACIT-Dyspnea are valid instruments to measure health status and dyspnea in patients with SSc. In physical function assessment, longer PROMIS short forms or computer adaptive testing should be considered to improve responsiveness to the effect of skin disease changes on physical function in patients with SSc.

摘要

目的

评估患者报告结局测量信息系统29项健康状况量表(PROMIS - 29)和慢性病治疗功能评估 - 呼吸困难10项简表(FACIT - 呼吸困难)在测量系统性硬化症(SSc)患者健康状况变化和呼吸困难方面的敏感性。

方法

100例SSc患者在基线和1年随访时完成了PROMIS - 29、FACIT - 呼吸困难量表以及传统工具[医学研究委员会呼吸困难评分、圣乔治呼吸问卷(SGRQ)、健康评估问卷 - 残疾指数(HAQ - DI)和医学结局研究简表36(SF - 36)]。比较了PROMIS - 29、FACIT - 呼吸困难量表和传统工具在综合改良梅斯格疾病严重程度和改良罗德南皮肤评分(mRSS)变化组中的变化分数。

结果

FACIT - 呼吸困难量表与SGRQ之间观察到中等偏高的斯皮尔曼相关系数(r = 0.57),FACIT - 呼吸困难量表功能受限与SF - 36身体成分总结(PCS;r = 0.51)、PROMIS - 29身体功能与HAQ - DI(r = 0.50)以及SF - 36 PCS(r = 0.52)变化分数之间也观察到中等偏高的斯皮尔曼相关系数。在大多数效度比较中,PROMIS - 29、FACIT - 呼吸困难量表、HAQ - DI和SF - 36分数表现相似。虽然PROMIS - 29涵盖的内容领域比SF - 36更多(例如睡眠),但与多项目衍生的SF - 36 PCS相比,其4项身体功能量表的反应性可能会受到影响。在mRSS改善的患者中,观察到SF - 36角色功能(p = 0.01)和身体成分量表(p = 0.016)有统计学意义的增加,但PROMIS - 29没有。

结论

PROMIS - 29和FACIT - 呼吸困难量表是测量SSc患者健康状况和呼吸困难的有效工具。在身体功能评估中,应考虑使用更长的PROMIS简表或计算机自适应测试,以提高对SSc患者皮肤疾病变化对身体功能影响的反应性。

相似文献

1
Longitudinal evaluation of PROMIS-29 and FACIT-dyspnea short forms in systemic sclerosis.
J Rheumatol. 2015 Jan;42(1):64-72. doi: 10.3899/jrheum.140143. Epub 2014 Nov 1.
3
Validation of the Swedish version of PROMIS-29v2 and FACIT-Dyspnea Index in patients with systemic sclerosis.
Disabil Rehabil. 2023 Jul;45(15):2517-2525. doi: 10.1080/09638288.2022.2096124. Epub 2022 Sep 21.
9
Use of the Patient-generated Index in systemic sclerosis to assess patient-centered outcomes.
J Rheumatol. 2013 Aug;40(8):1337-43. doi: 10.3899/jrheum.120978. Epub 2013 Jun 15.

引用本文的文献

2
Peer mentoring program through a digital platform for people with systemic sclerosis: A feasibility study.
J Scleroderma Relat Disord. 2024 Nov 11:23971983241295911. doi: 10.1177/23971983241295911.
4
Reliability and validity of the Turkish version of Scleroderma Skin Patient-Reported Outcome in patients with systemic sclerosis.
Arch Rheumatol. 2023 Jun 14;39(1):52-59. doi: 10.46497/ArchRheumatol.2023.10183. eCollection 2024 Mar.
5
Reliability and validity of the PROMIS-29 health profile in Ankylosing Spondylitis patients: A cross-sectional study.
Medicine (Baltimore). 2024 Mar 1;103(9):e37251. doi: 10.1097/MD.0000000000037251.
6
Quality Measures in Systemic Sclerosis.
Diagnostics (Basel). 2023 Feb 4;13(4):579. doi: 10.3390/diagnostics13040579.
8
Predictors and Interrelationship of Patient-Reported Outcomes in Antiphospholipid Syndrome: A Cross-Sectional Study.
ACR Open Rheumatol. 2023 Jan;5(1):28-37. doi: 10.1002/acr2.11512. Epub 2022 Dec 2.
10
Differences in symptom experience among patients with systemic sclerosis: a cluster analytic approach to identifying subgroups.
Rheumatology (Oxford). 2023 Feb 6;62(SI):SI64-SI73. doi: 10.1093/rheumatology/keac444.

本文引用的文献

3
Text data extraction for a prospective, research-focused data mart: implementation and validation.
BMC Med Inform Decis Mak. 2012 Sep 13;12:106. doi: 10.1186/1472-6947-12-106.
4
Renal disease in scleroderma: an update on evaluation, risk stratification, pathogenesis and management.
Curr Opin Rheumatol. 2012 Nov;24(6):669-76. doi: 10.1097/BOR.0b013e3283588dcf.
5
Feasibility and construct validity of PROMIS and "legacy" instruments in an academic scleroderma clinic.
Value Health. 2012 Jan;15(1):128-34. doi: 10.1016/j.jval.2011.08.006. Epub 2011 Oct 22.
7
A brief symptom index for advanced lung cancer.
Clin Lung Cancer. 2012 Jan;13(1):14-23. doi: 10.1016/j.cllc.2011.03.033. Epub 2011 May 23.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验